Evidence map›Paper›PMID 36831939›Full record

ArticleBiosensors2023

An Ultrasensitive miRNA-Based Genosensor for Detection of MicroRNA 21 in Gastric Cancer Cells Based on Functional Signal Amplifier and Synthesized Perovskite-Graphene Oxide and AuNPs.

Payam Shahbazi-Derakhshi, Elham Mahmoudi, Mir Mostafa Majidi, Hessamaddin Sohrabi, Mohammad Amini, Mir Reza Majidi, Aligholi Niaei, Nima Shaykh-Baygloo, Ahad Mokhtarzadeh

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. The potential role of miR-155 in the tumorigenesis of cervical cancer.Frontiers in cell and developmental biology · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Payam Shahbazi-DerakhshiDepartment of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz 5166-616471, Iran.
Elham MahmoudiCatalyst and Reactor Research Lab, Department of Chemical & Petroleum Engineering, University of Tabriz, Tabriz 5166-616471, Iran.
Mir Mostafa MajidiCatalyst and Reactor Research Lab, Department of Chemical & Petroleum Engineering, University of Tabriz, Tabriz 5166-616471, Iran.
Hessamaddin SohrabiDepartment of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz 5166-616471, Iran.
Mohammad AminiImmunology Research Center, Medical Science University of Tabriz, Tabriz 5166-15731, Iran.
Mir Reza MajidiDepartment of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz 5166-616471, Iran.
Aligholi NiaeiCatalyst and Reactor Research Lab, Department of Chemical & Petroleum Engineering, University of Tabriz, Tabriz 5166-616471, Iran.
Nima Shaykh-BayglooDepartment of Biology, Faculty of Science, Urmia University, Urmia 5756-151818, Iran.ORCID 0000-0002-8883-0548
Ahad MokhtarzadehImmunology Research Center, Medical Science University of Tabriz, Tabriz 5166-15731, Iran.
University of Tabriz · IRAmirkabir University of Technology · IRUrmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present research work, the state-of-art label-free electrochemical genosensing platform was developed based on the hybridization process in the presence of [Fe(CN)

Indexed as

Biosensing TechniquesGraphiteMetal NanoparticlesMicroRNAsStomach NeoplasmsCalcium CompoundsElectrochemical TechniquesElectrodesGoldHumansLimit of DetectionOxidesReproducibility of ResultsTitaniumCalcium CompoundsGoldgraphene oxideGraphiteMicroRNAsMIRN21 microRNA, humanOxidesperovskiteTitaniumelectrochemical genosensinggastric cancergold nanoparticlesmiRNA-21perovskite

Identifiers

PMID36831939
PMCPMC9953341
OpenAlexW4317733972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.